These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15578968)

  • 1. New aminoacyl-tRNA synthetase inhibitors as antibacterial agents.
    Pohlmann J; Brötz-Oesterhelt H
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):261-72. PubMed ID: 15578968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods to assay inhibitors of tRNA synthetase activity.
    Beyer D; Kroll HP; Brötz-Oesterhelt H
    Methods Mol Med; 2008; 142():53-61. PubMed ID: 18437305
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aminoacyl-tRNA synthetase inhibitors as potent antibacterials.
    Lv PC; Zhu HL
    Curr Med Chem; 2012; 19(21):3550-63. PubMed ID: 22680640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of aminoacyl-tRNA synthetases as antimycobacterial compounds: An up-to-date review.
    Bouz G; Zitko J
    Bioorg Chem; 2021 May; 110():104806. PubMed ID: 33799176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the targets of aminoacyl-tRNA synthetase inhibitors by primer extension inhibition.
    Orelle C; Szal T; Klepacki D; Shaw KJ; Vázquez-Laslop N; Mankin AS
    Nucleic Acids Res; 2013 Aug; 41(14):e144. PubMed ID: 23761439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminoacyl-tRNA synthetase inhibitors as potential antibiotics.
    Vondenhoff GH; Van Aerschot A
    Eur J Med Chem; 2011 Nov; 46(11):5227-36. PubMed ID: 21968372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoacyl-tRNA synthetase inhibitors as antimicrobial agents: a patent review from 2006 till present.
    Gadakh B; Van Aerschot A
    Expert Opin Ther Pat; 2012 Dec; 22(12):1453-65. PubMed ID: 23062029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoacyl-tRNA synthetases and their inhibitors as a novel family of antibiotics.
    Kim S; Lee SW; Choi EC; Choi SY
    Appl Microbiol Biotechnol; 2003 May; 61(4):278-88. PubMed ID: 12743756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glutaminyl-tRNA Synthetase from Pseudomonas aeruginosa: Characterization, structure, and development as a screening platform.
    Escamilla Y; Hughes CA; Abendroth J; Dranow DM; Balboa S; Dean FB; Bullard JM
    Protein Sci; 2020 Apr; 29(4):905-918. PubMed ID: 31833153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Search for inhibitors of aminoacyl-tRNA synthases by virtual click chemistry.
    Hoffmann M; Torchala M
    J Mol Model; 2009 Jun; 15(6):665-72. PubMed ID: 19048310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress and challenges in aminoacyl-tRNA synthetase-based therapeutics.
    Francklyn CS; Mullen P
    J Biol Chem; 2019 Apr; 294(14):5365-5385. PubMed ID: 30670594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitors of aminoacyl-tRNA synthetases as novel anti-infectives.
    Tao J; Schimmel P
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1767-75. PubMed ID: 11060775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New class of bacterial phenylalanyl-tRNA synthetase inhibitors with high potency and broad-spectrum activity.
    Beyer D; Kroll HP; Endermann R; Schiffer G; Siegel S; Bauser M; Pohlmann J; Brands M; Ziegelbauer K; Haebich D; Eymann C; Brötz-Oesterhelt H
    Antimicrob Agents Chemother; 2004 Feb; 48(2):525-32. PubMed ID: 14742205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A consequence of drug targeting of aminoacyl-tRNA synthetases in Mycobacteriumtuberculosis.
    Ndagi U; Kumalo HM; Mhlongo NN
    Chem Biol Drug Des; 2021 Sep; 98(3):421-434. PubMed ID: 33993612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosyl-tRNA synthetase inhibitors: a patent review.
    Sun J; Lv PC; Zhu HL
    Expert Opin Ther Pat; 2017 May; 27(5):557-564. PubMed ID: 27977303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting Multiple Aminoacyl-tRNA Synthetases Overcomes the Resistance Liabilities Associated with Antibacterial Inhibitors Acting on a Single Such Enzyme.
    Randall CP; Rasina D; Jirgensons A; O'Neill AJ
    Antimicrob Agents Chemother; 2016 Oct; 60(10):6359-61. PubMed ID: 27431224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simultaneous screening of multiple bacterial tRNA synthetases using an Escherichia coli S30-based transcription and translation assay.
    Dermyer M; Wise SC; Braden T; Holler TP
    Assay Drug Dev Technol; 2007 Aug; 5(4):515-21. PubMed ID: 17767419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and characterization of a novel class of pyrazolopyrimidinedione tRNA synthesis inhibitors.
    Montgomery JI; Smith JF; Tomaras AP; Zaniewski R; McPherson CJ; McAllister LA; Hartman-Neumann S; Arcari JT; Lescoe M; Gutierrez J; Yuan Y; Limberakis C; Miller AA
    J Antibiot (Tokyo); 2015 Jun; 68(6):361-7. PubMed ID: 25464974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery.
    Pang L; Weeks SD; Van Aerschot A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33578647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative analysis of pyrimidine substituted aminoacyl-sulfamoyl nucleosides as potential inhibitors targeting class I aminoacyl-tRNA synthetases.
    Nautiyal M; De Graef S; Pang L; Gadakh B; Strelkov SV; Weeks SD; Van Aerschot A
    Eur J Med Chem; 2019 Jul; 173():154-166. PubMed ID: 30995568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.